FIELD: biotechnologies.
SUBSTANCE: composition contains pluripotent cells of a mammal and a pharmaceutically acceptable carrier. Besides, a generation method of reprogrammed somatic cell is disclosed. Proposed group of inventions can be used in cell therapy field.
EFFECT: possibility of using the method for cell therapy.
24 cl, 5 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STIMULATION OF PATHWAY Wnt IN REPROGRAMMING SOMATIC CELLS | 2008 |
|
RU2492232C2 |
| PERSONALISED PRODUCTION OF BIOPREPARATIONS AND STEM CELL REPROGRAMMING METHOD | 2012 |
|
RU2595390C2 |
| METHOD FOR PRODUCING HIGH-QUALITY INDUCED PLURIPOTENT STEM CELLS (IPSC) | 2016 |
|
RU2721266C1 |
| METHOD FOR INCREASING RNA EXPRESSION IN CELL | 2018 |
|
RU2784654C2 |
| TRANSIENT CELLULAR REPROGRAMMING TO REVERSE CELL AGING | 2019 |
|
RU2801316C2 |
| IMPROVING ORGANS FOR TRANSPLANTATION | 2014 |
|
RU2665364C2 |
| CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS | 2014 |
|
RU2675928C2 |
| METHOD FOR PRODUCING INDUCED REPROGRAMMED DERIVATIVE NEURONAL STEM CELLS FROM NON-NEURONAL CELLS BY USING HMGA2 | 2014 |
|
RU2646099C2 |
| IMPROVEMENT OF ORGANS FOR TRANSPLANTATION | 2014 |
|
RU2778304C2 |
| CELL COMPOSITIONS OBTAINED FROM DEDIFFERENTIATED REPROGRAMMED CELLS | 2014 |
|
RU2754089C2 |
